-
Valeant Management On Q1 Call: 'We Don't Feel We Can Accurately Predict' GAAP Earnings
Tuesday, June 7, 2016 - 10:25am | 283Read More...Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) hit a new 52-week low of $22.52 on Tuesday after the company released an investor presentation in conjunction with its first quarter results and conference call. Valeant earned $1.27 per share in the first quarter on revenue of $2.4 billion...
-
Valeant Withdraws Prior Guidance, Announces CEO Mike Pearson Will Return To Work Immediately Following Pneumonia Scare
Monday, February 29, 2016 - 8:35am | 250Read More...Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) plunged more than 8 percent early Monday morning after the company issued a business update over the weekend. Valeant confirmed that Michael Pearson will resume his role as CEO, effective immediately. The executive was hospitalized...
